Pfizer Inc. (PFE)


Stay up to date

Pfizer applies science and its global resources to bring therapies to people that extend and significantly improve their lives. It strives to set the standard for quality, safety and value in the discovery, development and manufacture of health care products, including innovative medicines and vaccines. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Consistent with its responsibility as one of the world's premier innovative biopharmaceutical companies, it collaborates with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. For more than 150 years, it has worked to make a difference for all who rely on it. It routinely posts information that may be important to investors on its website at

Financial Statements

Key Info

  • Industry: Pharmaceutical Preparation Manufacturing
  • Sector: Manufacturing
  • CEO Name: Albert Bourla

Key Statistics

  • Stock Price: $46.94
  • Dividend Yield: 3.3000000000000003%
  • Market Capitalization: $267,845,994,057
  • Shares Outstanding: 5,612,866,598
  • Number of Employees: 78,500
  • Trailing 12-Month EPS: $3.85
  • Trailing 12-Month DPS: $1.55
  • Payout Ratio: 40.300000000000004%

Important Dates

  • Next Earnings Date: 2022-05-03
  • Next Ex-Dividend Date: 2022-01-27

Price Trends

  • Current Stock Price: $46.94
  • 52-week high: $61.24
  • 52-week low: $32.29
  • 200-day moving average: $49.03
  • 50-day moving average: $51.91


  • 1-Month Price Return: -10.6%
  • 3-Month Price Return: -11.0%
  • 6-Month Price Return: 4.1%
  • 1-Year Price Return: 47.6%
  • 2-Year Price Return: 51.0%
  • 5-Year Price Return: 67.7%

Visit the Passiv Stock Directory

Data provided by IEX Cloud

For Canadian securities, listen to free conference calls on the TSX Quarterly Podcast